A little over a year ago, California’s insurance commissioner began investigating Aetna for possibly denying care coverage without reviewing the records of a patient who’d filed a lawsuit. Now the company has agreed to an out-of-court settlement.

The FDA has expanded Praluent’s (alirocumab) regulatory approval to reflect the reduced risk of heart attack, stroke and unstable angina evidenced in 2018’s ODYSSEY OUTCOMES trial—a move announced the same day drugmaker Sanofi released its first-quarter earnings, which were lower than expected.

Healthcare is a major voter issue, but many Americans tend to trust Democrats more than Republicans in this area heading into the 2020 election, according to a new poll from the Associated Press-NORC Center for Public Affairs Research.

HHS and CMS have launched a set of new payment models, dubbed the Primary Cares Initiative, that aim to transform primary care through value-based options. The new models will also test financial risk and performance-based payments for primary care practitioners and clinicians.

CMS saw an influx of public commentary after it first published a draft of recommendations for revising the United States’ national coverage determination (NCD) for transcatheter aortic valve replacement (TAVR) more than a month ago. Now that the 30-day comment period is over, the agency has a decision to make.

The FDA wants manufacturers to include additional information in premarket submissions for medical devices that include quantitative imaging functions, according to a new draft guidance from the federal agency.

On April 25, National Take Your Child to Work Day, Siemens Healthineers used materials developed by the American Society of Radiologic Technologists (ASRT) to educate and entertain 100 children during an all-day event.

Ten years from now, more than 14 million middle-class Americans will be elderly, mobility-limited and in need of more healthcare services and specialized senior housing than they’ll be able to afford.